{"id":901,"date":"2022-02-13T12:14:20","date_gmt":"2022-02-13T12:14:20","guid":{"rendered":"https:\/\/libertatisergo.com\/?p=901"},"modified":"2022-02-15T15:31:15","modified_gmt":"2022-02-15T15:31:15","slug":"imuno-therapeutics","status":"publish","type":"post","link":"https:\/\/libertatisergo.com\/nl\/imuno-therapeutics\/","title":{"rendered":"Imuno Therapeutics"},"content":{"rendered":"
[et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” disabled_on=”off|off|off” _builder_version=”4.14.7″ _module_preset=”default” min_height=”120px” custom_margin=”-4%||||false|false” custom_margin_tablet=”||||false|false” custom_margin_phone=”-60px||-20px||false|false” custom_margin_last_edited=”on|tablet” custom_padding=”5px||5px|30px|true|false” custom_padding_tablet=”0px||0px|30px|true|false” custom_padding_phone=”5px|30px|5px|30px|true|true” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.14.7″ _module_preset=”default” width=”100%” custom_padding=”||0px|||” custom_css_main_element=”display: flex;” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/libertatisergo.com\/wp-content\/uploads\/2022\/01\/Logo-1.png” title_text=”Logo” url=”\/home” _builder_version=”4.14.7″ _module_preset=”default” width=”60%” width_tablet=”50%” width_phone=”100%” width_last_edited=”on|tablet” module_alignment=”left” custom_margin=”||||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.14.7″ _module_preset=”default” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_menu menu_id=”3″ submenu_direction=”downwards” active_link_color=”#001158″ dropdown_menu_line_color=”#001158″ dropdown_menu_text_color=”#001158″ active_link_color_tablet=”#001158″ active_link_color_phone=”#001158″ active_link_color_last_edited=”on|tablet” _builder_version=”4.14.7″ _module_preset=”default” menu_text_color=”#001158″ menu_font_size=”16px” text_orientation=”right” custom_margin=”||||false|false” custom_padding=”15px||||false|false” custom_padding_tablet=”0px|25px|||false|false” custom_padding_phone=”|0px|||false|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}”][\/et_pb_menu][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.14.7″ _module_preset=”default” background_color=”#001158″ custom_padding=”2%||2%||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.14.7″ _module_preset=”default” header_text_color=”#FFFFFF” header_font_size=”45px” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.14.7″ _module_preset=”default” background_color=”#d9dce6″ custom_padding=”2%||2%||false|false” global_colors_info=”{}”][et_pb_row column_structure=”3_5,2_5″ _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”3_5″ _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.14.7″ _module_preset=”default” header_text_color=”#001158″ header_font_size=”45px” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=”4.14.7″ _module_preset=”default” text_text_color=”#001158″ global_colors_info=”{}”]<\/p>\n
19 november 2021, investeren LEH en UNIIQ in totaal \u20ac300.000 in startkapitaal voor Imuno Therapeutics B.V., een nieuw Leids bedrijf in immunotherapietechnologie. Imuno zal de fondsen gebruiken om het bereik van kankerspecifieke epitopen te verbreden en zo de basis te leggen voor nieuwe gerichte therapie\u00ebn.<\/p>\n
https:\/\/www.imunotx.com<\/a>\u00a0\u00a0<\/span><\/p>\n <\/p>\n